Teladoc (NYSE: TDOC) executive sale covers taxes and adds 173,010 RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Teladoc Health executive Carlos Nueno reported multiple equity transactions involving Teladoc Health, Inc. common stock and equity awards. On March 2, 2026, he sold 20,165 shares of common stock in an open‑market transaction at $5.117 per share, with a footnote stating the sale was to cover tax withholding obligations from vesting awards.
On March 1, 2026, he received a grant of 173,010 restricted stock units with each unit representing a contingent right to one Teladoc share. On February 27, 2026, several blocks of restricted stock units and performance stock units converted into common stock on a one‑for‑one basis, increasing his shareholdings. After these transactions, he directly owned 50,595 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 20,165 shares ($103,184)
Net Sell
10 txns
Insider
Nueno Carlos
Role
President, International
Sold
20,165 shs ($103K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,165 | $5.117 | $103K |
| Grant/Award | Restricted Stock Units | 173,010 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,101 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,556 | $0.00 | -- |
| Exercise | Restricted Stock Units | 34,867 | $0.00 | -- |
| Exercise | Performance Stock Units | 1,061 | $0.00 | -- |
| Exercise | Common Stock | 3,101 | $0.00 | -- |
| Exercise | Common Stock | 4,556 | $0.00 | -- |
| Exercise | Common Stock | 34,867 | $0.00 | -- |
| Exercise | Common Stock | 1,061 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 50,595 shares (Direct);
Restricted Stock Units — 173,010 shares (Direct);
Performance Stock Units — 0 shares (Direct)
Footnotes (1)
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
FAQ
What insider transactions did Teladoc (TDOC) executive Carlos Nueno report?
Carlos Nueno reported a combination of stock sales, grants, and conversions. He sold common shares to cover tax withholding and received a large restricted stock unit grant, while several earlier RSU and performance stock unit awards converted into Teladoc common stock.
What new equity awards did Carlos Nueno receive from Teladoc (TDOC)?
Carlos Nueno received a grant of 173,010 restricted stock units on March 1, 2026. Each restricted stock unit represents a contingent right to receive one share of Teladoc common stock, subject to the award’s vesting schedule and other terms described in the company’s equity plans.